Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (251-260 of 421) with videos related to

Pageof 43
Sort By:
Antimicrobial Agents and Chemotherapy|June 4, 2014
Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complexTeena Chopra, Dror Marchaim, Paul C Johnson, et al.
Infection Control and Hospital Epidemiology|December 29, 2020
Antimicrobial never events: Objective application of a framework to assess vancomycin appropriatenessJiajun Liu, Nicholas J Mercuro, Susan L Davis, et al.
American Journal of Infection Control|December 2, 2015
Risk factors and acute in-hospital costs for infected pressure ulcers among gunshot-spinal cord injury victims in southeastern MichiganTeena Chopra, Dror Marchaim, Reda A Awali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremiaChristopher W Woods, Adam M Bressler, John J LiPuma, et al.
JMIR Mhealth and Uhealth|December 18, 2020
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2019
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized TrialKeith S Kaye, Louis B Rice, Aaron L Dane, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2014
Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniaeDavid van Duin, Eric Cober, Sandra S Richter, et al.
Infection Control and Hospital Epidemiology|December 30, 2016
Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections?Anthony D Harris, Lisa Pineles, Deverick Anderson, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Effectiveness of piperacillin/tazobactam loading dose for extended infusion dosing among patients with Gram-negative bacteraemiaSavan Patel, Sana Mohayya, Arsheena Yassin, et al.
JMIR Mhealth and Uhealth|December 16, 2020
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Pageof 43

Showing results (251-260 of 421) with videos related to

Sort By:
Pageof 43
Antimicrobial Agents and Chemotherapy|June 4, 2014
Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complexTeena Chopra, Dror Marchaim, Paul C Johnson, et al.
Infection Control and Hospital Epidemiology|December 29, 2020
Antimicrobial never events: Objective application of a framework to assess vancomycin appropriatenessJiajun Liu, Nicholas J Mercuro, Susan L Davis, et al.
American Journal of Infection Control|December 2, 2015
Risk factors and acute in-hospital costs for infected pressure ulcers among gunshot-spinal cord injury victims in southeastern MichiganTeena Chopra, Dror Marchaim, Reda A Awali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremiaChristopher W Woods, Adam M Bressler, John J LiPuma, et al.
JMIR Mhealth and Uhealth|December 18, 2020
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2019
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized TrialKeith S Kaye, Louis B Rice, Aaron L Dane, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2014
Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniaeDavid van Duin, Eric Cober, Sandra S Richter, et al.
Infection Control and Hospital Epidemiology|December 30, 2016
Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections?Anthony D Harris, Lisa Pineles, Deverick Anderson, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Effectiveness of piperacillin/tazobactam loading dose for extended infusion dosing among patients with Gram-negative bacteraemiaSavan Patel, Sana Mohayya, Arsheena Yassin, et al.
JMIR Mhealth and Uhealth|December 16, 2020
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Pageof 43